Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 5Phase 3 2Phase 1/2 2Phase NA 1

Status

Unknown 2Completed 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Gliosarcoma 1Glioma 1Glioblastoma 1Gallbladder Neoplasms 1Central Nervous System Neoplasms 1Brain Neoplasms 1Bile Duct Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 299Cisplatin 298Paclitaxel 257Radiotherapy 255Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 216Dexamethasone 166Gemcitabine 156Vincristine 147Etoposide 136Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Completed × Dihematoporphyrin Ether × Clear all
NCT00513539 2013-02-20

Photostent-02

University College, London

Phase 3 Completed
92 enrolled
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms

NCT00118222 2010-06-11

High Light and Low Light Dose PDT in Glioma

Case Comprehensive Cancer Center

Phase 3 Completed
1 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡